Skip to main navigation Skip to search Skip to main content

ACcomplisH: A Phase 2, multicenter, double-blind, randomized, placebo-controlled, dose esculation trial evaluating safety, efficacy, and pharmacokinectics of subcutaneous doses of TransCon CNP administered qwk for 12 mo in prepubertal wit

University at Buffalo

Project: Research

Project Details

StatusFinished
Effective start/end date02/26/20 → 02/26/26

Funding

  • Veristat LLC: $272,542.34